IL1B and Alzheimer disease: Furthermore, chronic production of IL-1β enhances brain acetylcholinesterase activity and microglia activation, producing a vitious circle of dysfunction that promotes AD progression by reducing the acetylcholine function and promoting inflammation (Rauf et al., 2022).